Phuong N. Huynh

Array ( [id] => 6710993 [patent_doc_number] => 20030170742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Polynucleotides and polypeptides associated with the development of rheumatoid arthritis' [patent_app_type] => new [patent_app_number] => 10/308279 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 110 [patent_figures_cnt] => 110 [patent_no_of_words] => 13821 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170742.pdf [firstpage_image] =>[orig_patent_app_number] => 10308279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 473136 [patent_doc_number] => 07230085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Anti-DOTA antibody' [patent_app_type] => utility [patent_app_number] => 10/305268 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17114 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/230/07230085.pdf [firstpage_image] =>[orig_patent_app_number] => 10305268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669400 [patent_doc_number] => 20030114384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Methods and compositions for treating lesions of the respiratory epithelium' [patent_app_type] => new [patent_app_number] => 10/305747 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8358 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114384.pdf [firstpage_image] =>[orig_patent_app_number] => 10305747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697253 [patent_doc_number] => 20030109447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Methods of use of recombinant vasoactive protein from salivary gland of the black fly' [patent_app_type] => new [patent_app_number] => 10/288740 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10593 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109447.pdf [firstpage_image] =>[orig_patent_app_number] => 10288740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668796 [patent_doc_number] => 20030113780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Antibodies to crosslinkers and methods for using the same' [patent_app_type] => new [patent_app_number] => 10/287341 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3453 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113780.pdf [firstpage_image] =>[orig_patent_app_number] => 10287341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796878 [patent_doc_number] => 20030175752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Methods and materials relating to CD39-like polypeptides' [patent_app_type] => new [patent_app_number] => 10/286926 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35349 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175752.pdf [firstpage_image] =>[orig_patent_app_number] => 10286926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869503 [patent_doc_number] => 20030082192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Multidrug multiligand conjugates for targeted drug delivery' [patent_app_type] => new [patent_app_number] => 10/281840 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5118 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082192.pdf [firstpage_image] =>[orig_patent_app_number] => 10281840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692220 [patent_doc_number] => 20030039652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Methods and pharmaceutical formulations for the treatment of pulmonary hypertension and methods for screening compounds useful in the treatment of pulmonary hypertension' [patent_app_type] => new [patent_app_number] => 10/274788 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8590 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039652.pdf [firstpage_image] =>[orig_patent_app_number] => 10274788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668313 [patent_doc_number] => 07094552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Diagnostic test kits' [patent_app_type] => utility [patent_app_number] => 10/272601 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3847 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094552.pdf [firstpage_image] =>[orig_patent_app_number] => 10272601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682733 [patent_doc_number] => 20030118597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Process for production of bee venom as pharmaceutical product which can be used effectively in the treatment of rheumatoid arthritis and viral diseases' [patent_app_type] => new [patent_app_number] => 10/268662 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3316 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118597.pdf [firstpage_image] =>[orig_patent_app_number] => 10268662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6800815 [patent_doc_number] => 20030095979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Pharmaceutical preparations comprising modified peptides' [patent_app_type] => new [patent_app_number] => 10/269171 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3588 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20030095979.pdf [firstpage_image] =>[orig_patent_app_number] => 10269171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6705838 [patent_doc_number] => 20030152572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Diagnostic and therapeutic agents for rheumatoid arthritis' [patent_app_type] => new [patent_app_number] => 10/240713 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8154 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152572.pdf [firstpage_image] =>[orig_patent_app_number] => 10240713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730678 [patent_doc_number] => 20030186868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Anti-angiogenic peptides' [patent_app_type] => new [patent_app_number] => 10/263162 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22460 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186868.pdf [firstpage_image] =>[orig_patent_app_number] => 10263162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7229780 [patent_doc_number] => 20040255983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Method for controlling environmental allergens' [patent_app_type] => new [patent_app_number] => 10/490782 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6250 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20040255983.pdf [firstpage_image] =>[orig_patent_app_number] => 10490782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656645 [patent_doc_number] => 20030077745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'ps20 amino acid sequences' [patent_app_type] => new [patent_app_number] => 10/252340 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14608 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077745.pdf [firstpage_image] =>[orig_patent_app_number] => 10252340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141713 [patent_doc_number] => 07691605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Selection of cells expressing heteromeric polypeptides' [patent_app_type] => utility [patent_app_number] => 10/251447 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8289 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691605.pdf [firstpage_image] =>[orig_patent_app_number] => 10251447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692214 [patent_doc_number] => 20030039646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Modulators of the function of receptors of the TNF/NGF receptor family and other proteins' [patent_app_type] => new [patent_app_number] => 10/245593 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20463 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039646.pdf [firstpage_image] =>[orig_patent_app_number] => 10245593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6744595 [patent_doc_number] => 20030021778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Ocular treatment by topical application of an immunoglobulin' [patent_app_type] => new [patent_app_number] => 10/246158 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5883 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021778.pdf [firstpage_image] =>[orig_patent_app_number] => 10246158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230691 [patent_doc_number] => 20050079170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Dimeric and multimeric antigen binding structure' [patent_app_type] => utility [patent_app_number] => 10/489626 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 12738 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079170.pdf [firstpage_image] =>[orig_patent_app_number] => 10489626 [rel_patent_id] =>[rel_patent_doc_number] =>)